Medicare Enrolled
Dr. Dipti Itchhaporia, MD
Cardiovascular Disease · Newport Beach, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Itchhaporia from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Itchhaporia?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Itchhaporia
Dr. Dipti Itchhaporia is a cardiovascular disease specialist in Newport Beach, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Itchhaporia performed 11,897 Medicare services across 4,737 unique beneficiaries.
Between the years covered by Open Payments, Dr. Itchhaporia received a total of $6,506 from 38 pharmaceutical and/or device companies across 140 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Itchhaporia is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 5% volume in CA
$6,506 industry payments
Medicare Practice Summary
Medicare Utilization ↗11,897
Medicare services
Top 5% in CA for cardiovascular disease
4,737
Unique beneficiaries
$41
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~626 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Inclisiran injection (Leqvio) for cholesterol | 3,692 | $9 | $15 |
| Adenosine injection, 1 mg Administration of a 1 mg dose of adenosine medication. This code is specifically for adenosine and excludes adenosine phosphate compounds. |
2,265 | $0 | $2 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
1,458 | $11 | $21 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,441 | $101 | $144 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
610 | $72 | $101 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
551 | $163 | $245 |
| Normal saline infusion, 250 cc Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid. |
312 | $0 | $2 |
| Remote pacemaker monitoring, 90 days Remote assessment of a pacemaker system, including single, dual, multiple lead, or leadless devices, performed up to 90 days apart. |
221 | $23 | $37 |
| Pacemaker programming, dual lead system Adjustment and configuration of a dual-lead pacemaker device to ensure proper operation and settings. |
200 | $29 | $94 |
| Technetium Tc-99m sestamibi diagnostic injection A diagnostic injection of technetium Tc-99m sestamibi used for imaging studies. |
156 | $98 | $220 |
| Stress echocardiogram with ECG monitoring An ultrasound of the heart performed while monitoring heart rhythm during rest, exercise, or medication-induced stress, followed by a review and report of the findings. |
143 | $201 | $283 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
119 | $168 | $236 |
| 2-day continuous ECG with review and report A two-day continuous electrocardiogram recording that includes a professional review and written report of the results. |
108 | $58 | $102 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
98 | $128 | $196 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
84 | $53 | $119 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
78 | $394 | $562 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
61 | $64 | $85 |
| Remote monitoring of implantable heart device, up to 30 days Remote evaluation of an implanted heart or blood vessel monitoring system over a period of up to 30 days. |
44 | $20 | $31 |
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
41 | $6 | $22 |
| Programming of dual lead implantable defibrillator system Adjustment and testing of the settings for an implanted heart device with two leads to ensure proper function. |
40 | $48 | $124 |
| Remote evaluation of implantable defibrillator system Remote assessment of a single, dual, or multiple lead implantable defibrillator system within 90 days of the previous evaluation. |
24 | $30 | $45 |
| External shock to heart to regulate heart beat A procedure that delivers an electric shock to the heart from outside the body to restore a normal heart rhythm. |
23 | $88 | $196 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
23 | $150 | $200 |
| Continuous external EKG monitoring, 48 hours to 7 days This procedure involves recording the heart's electrical activity continuously using an external device for a period exceeding 48 hours but not more than 7 days. |
18 | $11 | $14 |
| Continuous EKG monitoring review, 48-7 days Review and interpretation of continuous external EKG recordings lasting more than 48 hours up to 7 days. |
17 | $19 | $25 |
| Pacemaker programming, single lead Adjustment and testing of a single-lead pacemaker to ensure it functions correctly. |
17 | $27 | $80 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
16 | $141 | $193 |
| Continuous ECG monitoring, up to 30 days Continuous heart rhythm monitoring for up to 30 days, including professional review and reporting of the results. |
13 | $21 | $30 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
13 | $12 | $27 |
| 30-day continuous ECG with patient-triggered event transmission and review This procedure involves continuous electrocardiogram monitoring for up to 30 days, including the transmission of patient-triggered events. A healthcare professional reviews the data and provides a report. |
11 | $758 | $997 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
11.5% high complexity
55.1% medium
33.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$6,506
Total received (2018-2024)
Avg $929/year across 7 years
Top 35% in CA for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
38
Companies
140
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,581 (55.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$2,925 (45.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$734
2023
$753
2022
$3,664
2021
$473
2020
$137
2019
$200
2018
$545
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Abbott Laboratories
$169
BIOTRONIK INC.
$88
Novo Nordisk Inc
$87
Impulse Dynamics (USA) Inc.
$75
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$75
E.R. Squibb & Sons, L.L.C.
$58
Boston Scientific Corporation
$48
Merck Sharp & Dohme LLC
$42
Baxter Healthcare
$30
SANOFI-AVENTIS U.S. LLC
$23
HEARTFLOW, INC.
$22
Medtronic, Inc.
$16
Top 3 companies account for 46.9% of 2024 payments
All-time payments by company (2018-2024) ›
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$3,001
AstraZeneca Pharmaceuticals LP
$378
Abbott Laboratories
$271
Novo Nordisk Inc
$267
CVRx, Inc.
$266
Corindus Inc.
$254
E.R. Squibb & Sons, L.L.C.
$253
Novartis Pharmaceuticals Corporation
$157
Merck Sharp & Dohme LLC
$127
BIOTRONIK INC.
$122
HeartFlow, Inc.
$106
Medtronic, Inc.
$102
Merck Sharp & Dohme Corporation
$87
Bardy Diagnostics, Inc.
$85
CMP Pharma, Inc.
$83
Impulse Dynamics (USA) Inc.
$75
SANOFI-AVENTIS U.S. LLC
$72
Boston Scientific Corporation
$68
Alnylam Pharmaceuticals Inc.
$64
Chiesi USA, Inc.
$63
Kestra Medical Technology Services, Inc.
$63
Gilead Sciences, Inc.
$60
Esperion Therapeutics, Inc.
$57
Lundbeck LLC
$49
Amgen Inc.
$45
ABIOMED
$38
AtriCure, Inc.
$36
Coala Life Inc
$36
Bayer HealthCare Pharmaceuticals Inc.
$36
Baxter Healthcare
$30
ATRICURE, INC.
$25
Astellas Pharma US Inc
$23
HEARTFLOW, INC.
$22
Amarin Pharma Inc.
$21
Medtronic Vascular, Inc.
$18
Kiniksa Pharmaceuticals, Ltd.
$16
Opsens Inc.
$15
Actelion Pharmaceuticals US, Inc.
$14
Top 3 companies account for 56.1% of all-time payments
Associated products mentioned in payments ›
AVEIR · Assure WCD · BIOMONITOR · Barostim Neo System · CAMZYOS · CONFIRM RX · Carnation Ambulatory Monitor · Carospir · Coala Heart Monitor · Confirm Rx · ELIQUIS · ENTRESTO · EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX · FARXIGA · FFRct · GENERAL TACHY · HeartWare HVAD · Hillrom - Cardiac Ambulatory Monitor · Impella · JOT DX · KENGREAL · Kerendia · LEXISCAN · LINQ II · LifeVest · MICRA · MULTAQ · MitraClip System · NEXLETOL · NORTHERA · Norliqva · ONPATTRO · Optimizer · OptoWire · Ozempic · Repatha · UPTRAVI · VERQUVO · Vascepa · WATCHMAN FLX · Wegovy
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (55%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Cardiologists within 10 mi
249
Per 100K population
7.9
County median income
$113,702
Nearest hospital
HOAG MEMORIAL HOSPITAL PRESBYTERIAN
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Itchhaporia is a clinical cardiology specialist, with above-average Medicare volume (top 5% in CA), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Itchhaporia experienced with inclisiran injection (leqvio) for cholesterol?
Based on Medicare claims data, Dr. Itchhaporia performed 3,692 inclisiran injection (leqvio) for cholesterol services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Itchhaporia receive payments from pharmaceutical companies?
Yes. Dr. Itchhaporia received a total of $6,506 from 38 companies across 140 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Itchhaporia's costs compare to other cardiologists in Newport Beach?
Dr. Itchhaporia's average Medicare payment per service is $41. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Itchhaporia) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Newport Beach
Browse cardiologists in Newport Beach ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in CA
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in CA
Which CA cardiologists receive the most from drug and device companies.
By company
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) Payments to Doctors
See all physicians who received payments from ZOLL Services LLC (A/K/A ZOLL LifeCor Corp).
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology